Skip to main content

Published locations for Ozanimod for relapsing MS shows long-term safety, efficacy with age differences

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Ozanimod for relapsing MS shows long-term safety, efficacy with age differences

User login

  • Reset your password
  • /content/ozanimod-relapsing-ms-shows-long-term-safety-efficacy-age-differences
  • /fedprac/article/263448/multiple-sclerosis/ozanimod-relapsing-ms-shows-long-term-safety-efficacy-age
  • /neurologyreviews/article/263448/multiple-sclerosis/ozanimod-relapsing-ms-shows-long-term-safety
  • /neurology/article/263448/multiple-sclerosis/ozanimod-relapsing-ms-shows-long-term-safety-efficacy
  • /neurology/msresourcecenter/article/263448/multiple-sclerosis/ozanimod-relapsing-ms-shows-long-term